West Chester University

Digital Commons @ West Chester University
Psychology Faculty Publications

Psychology

1-2021

Experiences of women with ovarian cancer during the COVID-19
pandemic: Examining intolerance of uncertainty and fear of
COVID-19 in relation to psychological distress
Erin M. Hill
Andriana Frost
Jamie D. Martin

Follow this and additional works at: https://digitalcommons.wcupa.edu/psych_facpub
Part of the Oncology Commons, and the Social Psychology Commons

Journal of Psychosocial Oncology

ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/wjpo20

Experiences of women with ovarian cancer during
the COVID-19 pandemic: Examining intolerance
of uncertainty and fear of COVID-19 in relation to
psychological distress
Erin M. Hill , Andriana Frost & Jamie D. Martin
To cite this article: Erin M. Hill , Andriana Frost & Jamie D. Martin (2021): Experiences of women
with ovarian cancer during the COVID-19 pandemic: Examining intolerance of uncertainty and
fear of COVID-19 in relation to psychological distress, Journal of Psychosocial Oncology, DOI:
10.1080/07347332.2021.1880524
To link to this article: https://doi.org/10.1080/07347332.2021.1880524

Published online: 09 Feb 2021.

Submit your article to this journal

Article views: 161

View related articles

View Crossmark data

Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=wjpo20

JOURNAL OF PSYCHOSOCIAL ONCOLOGY
https://doi.org/10.1080/07347332.2021.1880524

ARTICLE

Experiences of women with ovarian cancer during the
COVID-19 pandemic: Examining intolerance of
uncertainty and fear of COVID-19 in relation to
psychological distress
Erin M. Hill, PhD, Andriana Frost, MS, and Jamie D. Martin, BA
Department of Psychology, West Chester University, West Chester, Pennsylvania, USA
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ABSTRACT

Purpose: Our research aimed to examine the role of intolerance of uncertainty (IU) in psychological distress (PD) among
women with ovarian cancer. Fear of COVID-19 (FCOV) was
examined as a mediator, and participant health status and the
reopening status of their geographic region were examined
as moderators.
Design: A cross-sectional quantitative design was employed.
Participants: Participants (n ¼ 100) were recruited through
various online sources and completed the study via Qualtrics.
Methods: Moderated mediation models and post-hoc linear
regression analyses were used to determine the role of predictor variables in PD.
Results: No significant moderators or mediators were found.
Despite a strong correlation between FCOV and IU, both variables explained unique variance in the anxiety and stress models, while FCOV was not significant in the depressive
symptoms model.
Implications for Providers: Both IU and FCOV should be
considered in helping women with ovarian cancer manage
their PD during the COVID-19 pandemic.

Fear of COVID-19;
intolerance of uncertainty;
ovarian cancer; perceived
health status; psychological
distress; reopening status

Introduction

Ovarian cancer is associated with significant mental and physical health
challenges.1–3 Due to the vague presentation of symptoms and lack of
population-wide screening, women with ovarian cancer are often not diagnosed until their cancer has progressed to an advanced stage.4
Correspondingly, the symptom burden, and the extensive and invasive
treatments can have a significant impact on physical functioning and quality of life.2,5 On top of an already difficult illness, the COVID-19 pandemic
presents additional challenges for this population; for example, individuals
with cancer experience elevated anxiety about their risk of contracting
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COVID-19,6 and significant strain in terms of managing treatment decisions in relation to the pandemic status in their community.7 Given the
lengthy and arduous disease and treatment trajectories that women with
ovarian cancer endure, coupled with the additional stressors brought on by
the COVID-19 pandemic, it is critical to understand factors associated with
mental health and well-being in this population.
There have been various psychological factors linked to mental health
among women with ovarian cancer, such as social support8 and coping strategies.9 One noteworthy characteristic linked to psychological distress (encompassing symptoms of depression, anxiety, stress10) is intolerance of uncertainty
(IU)—defined as the extent to which an individual experiences difficulty in the
face of uncertain circumstances.11 In addition to being a correlate of psychological distress, trait IU is also considered a vulnerability factor for a range of
mental health disorders12 and has been linked to fear of COVID-19 as well as
health anxiety in the context of the COVID-19 pandemic.13,14 Among women
with ovarian cancer, IU has been linked to depressive symptoms, anxiety, and
loneliness.8 Given that the COVID-19 pandemic is marked by many uncertainties (e.g., uncertainty about contracting the virus, the impact to healthcare),
it is likely that women with ovarian cancer with elevated levels of IU are also
likely to experience psychological distress during this challenging time.
In addition to IU, it is important to examine how women with ovarian
cancer perceive the viral threat of COVID-19. In helping to understand the
extent to which individuals in the general population fear COVID-19,
Ahorsu et al.15 developed the fear of COVID-19 (FCOV) scale—and found
that the construct was positively correlated with depressive symptoms, anxiety, perceived infectability of the virus, and germ aversion. Subsequent
research has reported similar findings; FCOV has been linked to depressive
symptoms and anxiety in other research,16,17 as well as decreased physical
and environmental quality of life.18 Furthermore, research supports the
notion that a greater FCOV is associated with more public health-compliant behaviors such as social distancing and regular hand washing.18
The relationship between IU and psychological distress along with the
potential mediating role of FCOV has been examined in the general population.13 Using a sample of Turkish individuals, Satici et al.13 found that
rumination and FCOV were serial mediators of the relationship between
IU and mental well-being. Similar research has examined IU and future
anxiety as mediators of the relationship between FCOV and well-being outcomes.16,19 Overall, the research suggests that uncertainty is particularly
salient during this pandemic—and may be associated with increased fear,
psychological distress, and health anxiety.20 Therefore, it is likely that for
women with ovarian cancer, having elevated levels of IU could fuel FCOV,
which, in turn, could contribute to or exacerbate psychological distress.
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When examining the relationship between IU and FCOV in the oncology
population, it is critical to take into account the health status of the individual
with cancer. There is evidence to suggest that patients are having their treatments delayed or modified due to the pandemic.7,21,22 Further, in a study conducted among women with ovarian cancer, Frey et al.7 found that most
participants were experiencing significant cancer worry, which, in turn, was
associated with being younger and having experienced a delay in oncology
care. Additionally, presuming an immunocompromised state was associated
with higher levels of worry, anxiety, and depression. Given the challenges associated with cancer—which have been compounded by the pandemic, it is possible that the relationship between IU and FCOV could be exacerbated among
individuals still undergoing treatment (not in remission) and/or among those
in an immunocompromised state (related to previous or current treatment).
In addition to health status, it is important to consider the severity of
the pandemic in each participant’s geographic region in terms of understanding the IU-FCOV relationship. Specifically, viral spread in relation to
the COVID-19 pandemic has been variable across geographic regions, both
within the United States and globally. Therefore, in the present study, to
help capture the severity of the pandemic, we measured the reopening status of each participant’s geographic region (specifically, the degree of lockdown being enforced). Research suggests that lockdown measures, which
may be necessary for helping to control the viral spread, have been associated with loneliness, psychological distress, and poorer life satisfaction.23
Therefore, it is possible that when viral spread is high (and strict lockdown
measures are in place), the relationship between IU and FCOV could be
stronger compared to circumstances where the viral spread is lower (and
lockdown measures are less strict).
The present study

The aim of the present study was to examine the relationship between IU (predictor variable) and psychological distress (outcome variable) among women
with ovarian cancer during the COVID-19 pandemic. FCOV was examined as
a mediator in the model; that is, we proposed that high levels of IU would be
associated with greater fears of COVID-19, consistent with previous research
on IU and FCOV,13 which, in turn, would be predictive of elevated levels of
psychological distress. We also examined health status and reopening status of
each participant’s geographic region as moderating variables in the relationship
between IU and FCOV in the model. Specifically, we proposed that for those
with poorer health status (not in remission or being immunocompromised),
the association between IU and FCOV would be stronger compared to those
who do not perceive their health as at risk. Finally, we wanted to take into
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Figure 1. Examining the indirect effect of intolerance of uncertainty on psychological distress
through fear of COVID-19: Testing health status and geographic reopening status as potential moderators.

account the pandemic reopening status of each participant’s geographic location—anticipating that the relationship between IU and FCOV would be stronger for individuals in geographic locations marked by a less controlled
pandemic state (and thus, stricter lockdown conditions). The overall model
tested in the present study is presented in Figure 1.
Method
Participants and procedures

Participants (n ¼ 100) were recruited through a variety of mechanisms:
email lists from our previously conducted studies, posts on social media
(e.g., Facebook, Twitter), and through various cancer-related organizations
(convenience sampling was employed). Inclusion criteria were the following: aged 18 years or older and having received a diagnosis of ovarian cancer. No exclusion criteria were applied. We did not set geographic
limitations in our recruitment (i.e., participants were recruited both within
and outside of the United States). In participating in the study, participants
completed the consent form, questions, and questionnaires via Qualtrics.
At the end of the study, participants had the opportunity to enter into a
draw for a $50 Amazon gift card. Data collection took place between July
and October 2020. During this time, COVID-19 cases continued to rise
globally. Within the United States, between July 1, 2020 and October 31,
2020, cases per day went from 35,575 to 89,048, with cumulative deaths rising from 126,573 to 227,178 during the time period.24 The study protocol
was approved by the authors’ institutional review board.
Measures
Intolerance of uncertainty

The 12-item Intolerance of Uncertainty Scale25 was used in the present
study. Participants responded to each item on a 5-point Likert scale ranging from 1 “not at all characteristic of me” to 5 “entirely characteristic of
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me.” Summing the items computes an overall IU score. In the present
study, the total scale had satisfactory internal consistency (a ¼ .89).
Fear of COVID-19

The 7-item Fear of COVID-19 Scale (FCS15) was used in the present study.
For each item of the scale, participants responded on a 5-point Likert scale
ranging from 1 “strongly disagree” to 5 “strongly agree.” A total score is
computed by summing the items. In the present study, the FCS had satisfactory internal consistency (a ¼ .85).
Psychological distress

The 21-item Depression Anxiety Stress Scales (DASS-21) were used to
measure psychological distress.10 Each construct is assessed with 7 items,
with each item rated on a 4-point Likert scale ranging from 0 “did not
apply to me at all” to 3 “applied to me very much, or most of the time.”
For each scale, items are summed and then multiplied by two to obtain a
score that is comparable to the 42-item DASS.10 In the present study, the
three scales had adequate internal consistency (anxiety symptoms; a ¼ .73;
depressive symptoms: a ¼ .92; stress: a ¼ .87).
Demographic and medical information

Participants were asked to provide information about their age, country of
residence, province/state, ethnicity, education level, marital status, employment status, and family income. They were also asked whether their
employment status and income were impacted by the COVID-19 pandemic. In terms of medical information, participants were asked about their
date of diagnosis, stage at diagnosis, current and previous treatments, current medical status (including whether they were in remission), to what
extent they feel they are immunocompromised (4-point scale: strongly disagree to strongly agree), their attribution about why they are immunocompromised, recurrence information, and other medical issues.
COVID-19 and other pandemic-related information

Participants were asked whether they have had COVID-19 (yes/no) and
whether the diagnosis was confirmed through testing (yes/no). They were
also asked to rate extent to which they agreed with the following statements: “Compared to the general population, I am at an elevated risk for
contracting COVID-19” and “If I were to contract COVID-19, compared
to the general population, the course of the illness would likely be more
severe.” Participants responded to each on a 4-point scale ranging from
strongly disagree (1) to strongly agree (4). Participants were asked to
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indicate why they believed they were at an elevated risk for contracting
COVID-19; they were provided with a list of options (listed in Table 1)
and they were able to indicate other reasons (open-ended). Participants
were also provided with a list of preventive health practices to avoid contracting COVID-19 (e.g., social distancing, wearing a face mask out in public) and participants were to select all that applied (listed in Table 1).
In order to capture the severity of the pandemic in each participant’s
geographic region, we provided participants with the reopening categories
used in the research team’s state, Pennsylvania (red: stay-at-home order in
place, life sustaining businesses only, large gatherings prohibited; yellow:
stay-at-home order lifted, in-person retail allowable (curbside/delivered
preferable), large gatherings of more than 25 prohibited; green: social gatherings of more than 250 prohibited, restaurants and bars can open at 50%
occupancy26) We then asked participants, “Using the above criteria, what
best describes the pandemic phase in your geographic location?” with red,
yellow, and green as response options. Participants could also elaborate on
their response in an open-ended textbox directly following the question.
Statistical approach

In examining the data, it became apparent that one individual in the study
had experienced COVID-19. Due to the focus of the study on IU and fears of
COVID-19, which might be mitigated as a result of experiencing the illness,
the individual was removed from the dataset and analyses were conducted
among the 99 participants who had not been diagnosed with COVID-19.
Regression assumptions were also examined; although outliers were identified
for the psychological distress variables, Cook’s distance indicated no influential
cases in the regressions. Therefore, all cases (n ¼ 99) were used to preserve
power. Our initial target sample size was at least 100; according to Cohen27
with a sample size of at least 91, we would have enough power (.8) to detect a
medium effect with regressions containing five predictor variables.
A series of moderated mediated regressions were conducted using
PROCESS in SPSS28 to examine whether there would be an indirect effect of
IU on psychological distress via FCOV, and the extent to which the relationship between IU and FCOV would be moderated by the individual’s health
status (remission status, perceived immunocompromised state) and geographic reopening status (red and yellow were combined vs. green). As will
be discussed in the results section, none of the moderating or mediating
effects were present when applying Models 7 and 9 of PROCESS. Therefore,
post-hoc linear regressions were conducted to examine the role of all predictors (IU, FCOV, immunocompromised status, remission, reopening status)
in psychological distress (depressive symptoms, anxiety, stress).

Category
Strongly disagree
Disagree
Agree
Strongly agree
Age
Health status
Personal living circumstances (e.g., living with frontline worker)
Current work circumstances (e.g., working as a frontline worker)
There is an outbreak of COVID-19 in my community
The functioning of my immune system
My experience with cancer
Medical conditions other than cancer
Strongly disagree
Disagree
Agree
Strongly agree
Engaging in social distancing (i.e., staying 6 feet or more from other people)
Washing hands often
Frequent cleaning and disinfecting your home/work environment
Avoiding large social gatherings
Minimizing attending large social gatherings
Wearing a face mask out in public
Red
Yellow
Green

n
10
18
47
24
38
50
10
10
20
40
54
16
5
20
56
18
96
97
78
87
62
96
9
49
42

%
10.1
18.2
47.5
24.2
38.4
50.5
10.1
10.1
20.2
40.4
54.5
16.2
5.1
20.2
56.6
18.2
97.0
98.0
78.8
87.9
62.6
97.0
9.1
48.5
42.4

Participants were able to select multiple responses. Note. Perceived risk for contracting COVID-19 – Participants were asked “How much do you agree with the following statement:
Compared to the general population, I am at risk for contracting COVID-19.” Perceived severity of COVID-19 if contracted – Participants were asked “How much do you agree with the
following statement? If I were to contract COVID-19, compared to the general population, the course of the illness would likely be more severe.”.

Pandemic-related reopening status in geographic region

Preventive health practices to avoid contracting COVID-19

Perceived severity of COVID-19 if contracted

Reasons for believing they are at risk

Perceived risk for contracting COVID-19

Variable

Table 1. Participant COVID-19-related experiences (n ¼ 100).
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Results
Descriptives and bivariate correlations

Demographic and medical information for the sample are presented in
Table 2. Participants in the present study ranged in age from 22 to 77
(M ¼ 55.03, SD ¼ 12.01), and had been diagnosed between 1 month and
421 months prior to participating (M ¼ 67.74, SD ¼ 62.61). Most women in
the study identified as Caucasian (n ¼ 90), were from the United States
(n ¼ 83), had completed college (n ¼ 71) and were married (n ¼ 57). In
terms of health status, most participants had been diagnosed at an
advanced stage (i.e., III or IV; n ¼ 61). While some women were in active
treatment related to presence of disease (n ¼ 25), the majority (n ¼ 69)
reported being in remission. Participants’ responses to the COVID-19related questions are presented in Table 1. Descriptive statistics and bivariate correlations for the psychosocial variables are presented in Table 3.
Moderated mediation and post-hoc linear regression analyses

Results from the moderated mediation regression analyses are presented in
Table 4. Notably, health status (perceived immunocompromised state,
remission status) and reopening status did not moderate the association
between IU and FCOV in the models. Accordingly, post-hoc linear regression models were conducted to instead examine the role of the predictor
variables (IU, FCOV, perceived immunocompromised state, remission status, reopening status) in psychological distress. Depressive symptoms, anxiety, and stress were each examined as outcome variables in three separate
regression analyses.
Standardized regression coefficients for each of the models are presented
in Table 5. The depressive symptoms model was significant (F (5, 93) ¼
6.88, p < .001, Adj. R2 ¼ .231), with IU (b ¼ .37, p ¼ .001) and reopening
status (b ¼ .26, p ¼ .006) as the only significant predictors. Higher levels
of IU were associated with depressive symptoms, and a more locked-down
status of the geographic area (red or yellow status) was associated with
increased depressive symptoms. The anxiety model was also significant (F
(5, 93) ¼ 12.70, p < .001, Adj. R2 ¼ .374), with FCOV emerging as the
strongest predictor (b ¼ .34, p ¼ .001), followed by IU (b ¼ .30, p ¼
.002), and then reopening status (b ¼ .17, p ¼ .041). IU and FCOV were
positively predictive of anxiety symptoms, and a more locked-down status
of the geographic area (red or yellow status) was associated with increased
anxiety symptoms. Finally, the stress model was also significant (F (5, 93)
¼ 14.00, p < .001, Adj. R2 ¼ .399), with IU emerging as the strongest predictor (b ¼ .37, p < .001), followed by FCOV (b ¼ .34, p ¼ .001).

n

7
2
23
17
25
22
3
57
5
18
5
14

90
2
1
1
4
1
83
3
11
1
1
34
37
18
10

%

7.1
2.0
23.2
17.2
25.3
22.2
3.0
57.6
5.1
18.2
5.1
14.1

90.9
2.0
1.0
1.0
4.0
1.0
83.8
3.0
11.1
1.0
1.0
34.3
37.4
18.2
10.1

Variable

Agreement with the statement:
“I am immunocompromised.”

Cancer recurrence
(for participants who
reported experiencing
recurrence after a period
of remission; n ¼ 44)

Current active treatments

Disease state at diagnosis

Current medical status

Category

Strongly disagree
Disagree
Agree
Strongly agree

Stage I
Stage II
Stage III
Stage IV
Missing
Surgery
Chemotherapy
Radiotherapy
Hormonal therapy
Other
1 time
2 times
3 times
4 times

Presence of disease, active treatment
Presence of disease, no treatment
Presence of disease, palliative treatment
In remission, no treatment
In remission, maintenance therapy

Medical Information

Note. Participants in remission and with presence of disease reported active treatments. Participants were also able to report multiple active treatments.

Marital status

Family income

Education
(completed)

$20,000 or less
$20,001-$30,000
$30,001-$50,000
$50,001-$70,000
$70,001-$100,000
$100,001 or more
Missing
Married
Living with a partner
Divorced/separated
Widowed
Single

Ethnicity

Country of origin

Category

Caucasian
Hispanic/Latino American
African American
Asian
Other
Missing
USA
UK
Canada
Kenya
Philippines
Postgraduate degree
College graduate
Trade school/some college
High school graduate

Variable

Demographics

Table 2. Participant sociodemographic and medical information.
n

17
17
47
18

26
10
51
10
2
4
23
0
5
12
28
10
2
4

25
3
2
52
17

%

17.2
17.2
47.5
18.2

26.3
10.1
51.5
10.1
2.0
4.0
23.2
0
5.1
12.1
28.3
10.1
2.0
4.0

25.3
3.0
2.0
52.5
17.2
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Table 3. Bivariate correlations among psychosocial variables.
Variable
M (SD)
Range
1
2
3
4
5
6
1. Fear of COVID-19
16.86 (5.76)
7-34
2. Intolerance of Uncertainty
28.97 (8.65) 14-50 .533
3. Depressive Symptoms
7.45 (8.67)
0-38 .332 .437
4. Anxiety Symptoms
5.41 (6.08)
0-30 .554 .497 .611
5. Stress
9.13 (8.02)
0-36 .552 .567 .743 .658
6. Perceived Risk of COVID-19
2.86 (.90)
1-4
.214
.140
.089
.211
.059
7. Perceived Severity of COVID-19 2.88 (.76)
1-4
.232
.191
.077
.196
.036 .302
p < 0.05; p < 0.01.
Note. For Perceived Risk of COVID-19 and Perceived Severity of COVID-19, participants were asked how much
they agreed whether they are at risk for COVID-19 and whether COVID-19 would be more severe if they contracted it compared to the general population. Response options were ranged from strongly disagree (1) to
strongly agree (4).

Table 4. Moderated mediation regression analyses examining the relationship of intolerance
of uncertainty and psychological distress via fear of COVID-19.
B (SE)

t

p

Health Status Variables as Moderators
FCOV as the outcome
IU
.30 (.13)
2.34
.021
immuno
1.51 (3.54)
.43
.671
remission
5.18 (3.61) 1.44 .154
IU x immuno
.02 (.12)
.14
.887
IU x remission
.11 (.12)
.90
.368
FCOV Model Statistics F (5, 93) ¼ 9.13, p < .001
Reopening Status
as a Moderator
FCOV as the outcome
IU
.43 (.08)
5.77 <.001
reopening
4.39 (3.44)
1.28
.204
IU x reopening
.20 (.12) 1.72 .089
FCOV Model Statistics F (3, 95) ¼ 14.71, p < .001
Final Model –
Depressive Symptoms
IU
.36 (.11)
3.37
.001
FCOV
.21 (.16)
1.29
.200
Final Model Statistics F (2, 96) ¼ 12.34, p < .001
Final Model – Anxiety
IU
.20 (.07)
2.92
.004
FCOV
.43 (.10)
4.21 <.001
Final Model Statistics F (2, 96) ¼ 27.45, p < .001
Final Model – Stress
IU
.35 (.09)
4.10 <.001
FCOV
.49 (.13)
3.77 <.001
Final Model Statistics F (2, 96) ¼ 33.14, p < .001

Final Model

B (SE)

t

p

Direct Effect in Health Status Moderator Model
Depressive symptoms
.36 (.11)
3.37
.001
Anxiety
.20 (.07)
2.92
.004
Stress
.35 (.09)
4.10
<.001

Direct Effect in Reopening
Depressive symptoms
Anxiety
Stress

Status Moderator Model
.36 (.11)
3.37
.001
.20(.07)
2.92
.004
.35 (.09)
4.10
<.001

Note: IU ¼ intolerance of uncertainty (total score from Intolerance of Uncertainty Scale-12; 25), FCOV ¼ fear of
COVID-19 (total score from the Fear of COVID-19 Scale; 15). The moderators were dummy coded; perceived
immunocompromised state (immuno), remission status (remission), and reopening status of geographic area
(reopening) were dichotomized (0 and 1, with 1 referring to being immunocompromised/in remission/green—
opened up (due to low amount of individuals in red geographic areas, red and yellow were combined)).
Conditional indirect effects are not presented due to non-significant moderator effects.

Discussion

In the present study, we examined IU and FCOV in relation to psychological distress among women with ovarian cancer. Health status (perceived
immunocompromised state, remission status) and the reopening status of
the participant’s geographic region were tested as moderators in the IU-
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Table 5. Post-hoc linear regression analyses examining psychosocial predictors of psychological distress.
Depressive symptoms
Predictors
Intolerance of uncertainty
Fear of COVID-19
Perceived immunocompromised state
Remission status
Reopening status of geographic area

Anxiety symptoms

Stress

b

p

b

p

b

p

.37
.08
.10
.03
2.26

.001
.480
.292
.710
.006

.30
.34
.12
.08
2.17

.002
.001
.132
.330
.041

.37
.34
.03
.05
.13

<.001
.001
.756
.565
.105

Note. Perceived immunocompromised state, remission status, and reopening status of geographic area were
dichotomized (0 and 1, with 1 referring to being immunocompromised/in remission/green—opened up (due
to low amount of individuals in red geographic areas, red and yellow were combined)). All models were statistically significant at p < .001; Depressive symptoms: F (5, 93) ¼ 6.88, p < .001, Adj. R2 ¼ .231; Anxiety symptoms, F (5, 93) ¼ 12.70, p < .001, Adj. R2 ¼ .374; Stress: F (5, 93) ¼ 14.00, p < .001, Adj. R2 ¼ .399.

FCOV relationship in the model. While the moderated mediation models
did not indicate significant mediation or moderator effects, the post-hoc
linear regression analyses indicated that IU, FCOV, and reopening status of
the region were predictive of psychological distress among women with
ovarian cancer during the pandemic.
Prior to interpreting the main results of the present study, it is worthwhile to note that psychological distress did not appear to be substantially
higher in the present study compared to previous work in this population
using the DASS-21.8,29 That is, we did not find evidence that women with
ovarian cancer are experiencing more psychological distress in the context
of the COVID-19 pandemic. Relatedly, although FCOV was correlated with
mental health outcomes in our study, the mean score in our sample was
lower than or similar to other samples, including among university
students.30–32 While the women in our sample did perceive themselves to
be at risk for COVID-19 and thought the disease course would be more
severe, their FCOV was not higher compared to other studies that have
also assessed FCOV.
With regard to the moderated mediation model examined, our overall
model was not supported in the present study. First, FCOV was not a significant mediator in the relationship between IU and psychological distress.
Indeed, the post-hoc linear regression models indicated that FCOV and IU
explained unique variance in the stress and anxiety models in particular.
Therefore, although FCOV and IU have a significant relationship—which is
similar to recent research13,33—it does not appear that FCOV helps to
explain the association between IU and psychological distress in the context
of the COVID-19 pandemic.
Additionally, the examination of the moderators indicated that the
strength of the relationship between FCOV and IU was not impacted by
participants’ health status (perceived immunocompromised state, remission
status) nor by the reopening status of their geographic region. The fears
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surrounding the pandemic therefore may not be directly related to the
objective risk of the individual—in terms of their health or the viral spread
in their community. This finding is similar to research on fears of recurrence (FCR) among women with ovarian cancer; FCR can be elevated for
individuals with both early and advanced disease34—and therefore, appears
unrelated to an individual’s objective risk for recurrence.
In light of the non-significant findings for the overall moderated mediation model, the predictors (IU, FCOV, perceived immunocompromised
state, remission status, reopening status) were examined in regressions
focused on depressive symptoms, anxiety, and stress. As mentioned previously, one notable finding from the post-hoc regressions was that both IU
and FCOV were predictive of anxiety and stress symptoms, indicating that
the variables explain unique variance in the psychological outcomes. This
finding could have direct implications for psychosocial care of individuals
with cancer in the context of the pandemic. That is, while it is intuitive
that IU and FCOV are related variables, they may need to be addressed as
distinct considerations in clinical or support settings. Intolerance-of-uncertainty therapy has been used to target psychological distress,35 but in addition to focusing on IU, it may be worthwhile to separately address fears
related to COVID-19—such fears associated with contracting the virus or
fears that the virus could impact cancer-related healthcare.
The results of the post-hoc regression analyses also indicated that a more
locked-down state in one’s geographic region was associated with psychological distress—specifically, anxiety and depressive symptoms, but not
stress. Similarly, the experience of lockdown has been associated with a
deterioration of mental health among individuals from the general population.36,37 It is possible that a more locked-down state represents uncontrolled viral spread, and thus could be a factor in exacerbating anxiety and
depressive symptoms, which might be particularly worrisome among individuals with ovarian cancer.
Furthermore, lockdowns impose restrictions on various daily behaviors
and have been linked to feelings of loneliness among individuals with
chronic conditions.38 Given the increased health anxiety among vulnerable
groups during the COVID-19 pandemic,20 it is possible that women with
ovarian cancer in more locked-down geographic locations (and, in turn,
with less controlled viral spread) might be particularly vulnerable to the
impact of the social isolation that comes with stay-at-home orders.
However, given that the present study did not focus on social interactions
or loneliness, this would be an important future area of study in the field
of psychosocial oncology. Specifically, it will be important to understand
how loneliness and social interactions are impacted by lockdowns—and
how such variables relate to psychological distress.

JOURNAL OF PSYCHOSOCIAL ONCOLOGY

13

In addition to examining factors associated with psychological distress
among women with ovarian cancer during the COVID-19 pandemic, our
research also collected various descriptive information about COVID-19
perceptions and preventive health behaviors. Notably, the majority of
women in our sample believed that they were at risk for contracting
COVID-19 and believed the course of illness would be more severe compared to the general population. The top reasons for believing they were at
risk were health-related; “my experience with cancer” was the top-endorsed
reason, followed by “health status,” and “the functioning of my immune
system.” Consistent with the literature on individuals with cancer and their
pandemic health-related behaviors,39 the engagement in preventive health
practices in the present sample was extremely high, with nearly all participants engaging in social distancing, washing hands often, wearing a face
mask in public, and most avoiding large social gatherings. Therefore,
although FCOV was not particularly high in our sample (compared to previous research.30–32) it appears that women with ovarian cancer engage in
various preventive health behaviors that help to protect their own health—
and the health of others—during the COVID-19 pandemic.
Limitations

There are some limitations that should be noted in relation to our study.
First, cross-sectional data were used in this study. Therefore, it is not possible to determine the temporal nature of the relationships. The data could
be susceptible to same source bias, for example. That is, although we positioned IU and FCOV as predictors of psychological distress, it is possible,
and perhaps expected, that reciprocal relationships might exist, and that
distress might fuel FCOV and/or IU. Longitudinal studies would be one
avenue to help address this issue and to better understand the temporal
nature of the observed relationships.
It should also be noted that all data collected were self-report. While this
is typical of psychological constructs, like IU and psychological distress,
participants also self-reported their health status (specifically, how immunocompromised they were) as well as the reopening status of their geographic
region. That is, we relied on participants’ interpretation of their province/
state/region’s reopening status and how that mapped onto the traffic light
system (red, yellow, green) used in Pennsylvania. Due to potential for subjective interpretation, it is possible inaccuracies impacted the present study.
Finally, it is important to note that the sample in our study may not be
representative of the population of women with ovarian cancer in various
ways. The majority of the sample were Caucasian, college-educated, married, and younger than the average woman with ovarian cancer (median
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age of 56 in the present study vs. median age of 63 at diagnosis40). While
25% of the sample were in active treatment at the time of data collection,
the majority of the sample reported being in remission—and thus, would
likely have had reduced concerns about accessing treatment/treatment
delays related to the pandemic. Additionally, it is noteworthy that financial
concerns have been linked to worse mental health in the context of the
pandemic.41 Given the family incomes reported in the present study, it is
possible that many women in the sample were protected against some of
the financial hardships associated with the pandemic.
It is also particularly important to note that women of color (including
Latina and African American women) were underrepresented in our sample. Given that Latino and African American communities have been disproportionately impacted by the COVID-19 pandemic in the United
States,42 this limitation of the sample needs to be emphasized and considered in interpreting the results. It will be important for future research on
oncology populations to make a concerted effort to obtain samples that are
representative of the population of interest—particularly in understanding
experiences related to the pandemic, which differ widely depending on
socioeconomic status, race, and ethnicity.
Conclusion

The present study examined factors associated with psychological distress
among women with ovarian cancer in the context of the COVID-19 pandemic. While our overall moderated mediation model was not supported,
our results indicated that IU was associated with anxiety, depressive symptoms, and stress, and FCOV was also associated with anxiety and stress.
Our models also indicated that living in a more locked-down geographic
region was associated with both depressive symptoms and anxiety.
Furthermore, our descriptive results indicate that women with ovarian cancer are concerned about contracting the virus, its potential severe course
due to their health status, and accordingly, engage in multiple preventive
health behaviors to help prevent contracting the virus. Given the ongoing
challenges associated with the COVID-19 pandemic for individuals with
cancer, examining how the pandemic and related circumstances, such as
delayed healthcare and stay-at-home orders, impact both mental health and
social well-being would be important avenues for future research.
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